Home Equities Score Is It Because Pulmatrix (PULM) Stock Is Struggling During Premarket Sessions?

Is It Because Pulmatrix (PULM) Stock Is Struggling During Premarket Sessions?

Pulmatrix Inc. (PULM) stock has been taking a dip of -19.62% today pre-market buoying at $2.13 as of 6:55 a.m. EST. The clinical-stage biopharmaceutical company has added +33.17% in the last session settling at $2.65. The decline came following today’s announcement by the company of a registered direct offering of nearly 20 million shares.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.  

Here’s the real scoop:


The 2021 Backdoor Crypto Portfolio (free)

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.

Sponsored


This morning, Pulmatrix announced it has entered into definitive agreements for the sale of 20,000,000 shares of the Company’s common stock with healthcare-focused institutional investors. The company is offering common stock priced at the market in a registered direct offering under Nasdaq rules for $2.00 per share. Assuming that all closing conditions are satisfied, the closing of the offering is expected to occur on or about February 16, 2021.

Read More

As the exclusive placement agent for the offering, H.C. Wainwright & Co. will be acting on behalf of the company. Before expenses, including placement agent fees and offering expenses, Pulmatrix is likely to have gross proceeds from this offering of $40,000,000. This offering will enable the Company to use the net proceeds as working capital and for general corporate needs.

Getting to know the Company:

Using proprietary iSPERSE technologies, Pulmatrix develops inhaled products with better efficacy and reduced side effects that are targeted against severe pulmonary and non-pulmonary diseases. The company’s patented pharmaceutical portfolio is initially focused on improving treatments for acute lung illnesses.

Company’s Portfolio:

The portfolio comprises Pulmazole, which is an antifungal treatment for ABPA patients, and PUR1800, a narrow-spectrum kinase for the treatment of patients with lung cancer. ISPERSE, a patented engineered dry powder distribution platform, is part of Pulmatrix, which aims to improve lung function by optimizing local concentrations and reducing adverse effects.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.  

Conclusion:

In the last session, the company closed the trading at $2.65, but the announcement of the offering at a per-share price of $2.00 came negatively impacting. So the share’s market price is likely been leveling itself with the offering price announced by the company.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Are The Financial Results Weighing On Senseonics (SENS) Stock In Premarket Today?

Shares of medical technology Senseonics Holdings, Inc. (NYSE American: SENS) has been declining -9.67% in pre-market session today falling to a price level of...

ReTo Eco-Solutions, Inc. (RETO) Stock Fell 6% In Pre-Market Trading

The provider of technology solutions around ecological environments ReTo Eco-Solutions, Inc. (NASDAQ: RETO) has been facing a drop in its stock price in pre-market...

Fulgent Genetics (FLGT) Stock Rocketed 34.46% In Extended Trading Following Strong Financial Results

Shares of the testing services and comprehensive testing solutions technology company Fulgent Genetics, Inc. (NASDAQ: FLGT) rocketed 34.46% in the after-hour trades on Thursday....

Severn Bancorp (SVBI) Stock Is Rising 27% Pre-Market, Thanks To Merger Deal

Severn Bancorp, Inc. (NASDAQ: SVBI) stock is trending upward minutes before start of the regular session today. The stock has been floating at $10.69...

What’s Driving The Lipocine Inc. (LPCN) Stock Higher Pre-Market Today?

Shares of biopharmaceutical company Lipocine Inc. (NASDAQ: LPCN) have been up trending in early hours trading today. As of 07:17 a.m. EST, the stock...

Evofem Biosciences (EVFM) – Stock Fell In Early Trades Today: Why?

Shares of the biopharmaceutical company Evofem Biosciences, Inc., (NASDAQ: EVFM) have been sinking in the early trades today. The stock was buoying at $2.205...

The Aqua Metals (AQMS) Stock Is An Pre-Market Upsurge of 13% For What Reason?

The metal recycling firm Aqua Metals, Inc. (NASDAQ: AQMS) is on an uptick today in premarket session. As of 09:08 a.m. EST, the stock...

Are The Financial Results Weighing On Senseonics (SENS) Stock In Premarket Today?

Shares of medical technology Senseonics Holdings, Inc. (NYSE American: SENS) has been declining -9.67% in pre-market session today falling to a price level of...

Related News

Why CLPS Inc. (CLPS) Stock Is Rising 30% In Pre-Market Session? Here Is An Explanation

Shares of the information technology firm CLPS Incorporation (Nasdaq: CLPS) have been climbing in the early pre-market session today. As of 08:06 a.m. EST,...

Why The Stock of Jaws Acquisition (JWS) Has Risen 12% After-Hours?

Share of the blank check company Jaws Acquisition Corp. (NYSE: JWS) has risen 11.99% in extended trading on Thursday. The company saw its share...

The Driving Force Behind 10% After-Hour Increase In Resideo Technologies (REZI) Stock

The provider of home comfort and security solutions worldwide, Resideo Technologies, Inc. (NYSE: REZI) surged by 9.86% in extended trading, bringing the stock to...

Why The KemPharm (KMPH) Stock Has Been Rising More Than 50% In Early Trades?

The specialty pharmaceutical company KemPharm, Inc. (NASDAQ: KMPH) has been seeing its shares skyrocketing in early trades today. As of 10:46 a.m. EST, the...

The Reason Behind 28% After-Hour Rise In Heat Biologics (HTBX) Stock

Heat Biologics, Inc. (NASDAQ: HTBX), a clinical-stage biopharmaceutical company focused on the development of immune system modulation therapies. On Tuesday saw the price of...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Insider Watchlist

Important Earnings

We do not sell or share your information with anyone.